Key result
Schizophrenia carries high, undertreated cardiovascular risk, with smoking prevalent in ~71% of patients.
Why the study?
Prevalence of cardiovascular risk factors among patients with schizophrenia treated with second generation antipsychotics was not well characterized in a low cardiovascular risk area.
Cross-Sectional (n=733)
Yes
Cardiovascular risk factors are highly prevalent but under-diagnosed and under-treated in patients with schizophrenia receiving second-generation antipsychotics.
Answers are grounded in this paper and cite their sources.
High CVRF prevalence in schizophrenia inpatients supports routine screening; leaves open antipsychotic causality.
OBJECTIVE: Prevalence of cardiovascular disease is high in schizophrenia. Our aim is to estimate the prevalence of cardiovascular risk factors (CVRF) among schizophrenia patients. METHOD: National cross-sectional study in patients diagnosed with schizophrenia under treatment with second generation antipsychotics and admitted to short-stay hospitalisation units. RESULTS: A sample of 733 consecutively admitted patients was enrolled; the most prevalent CVRFs were smoking 71% (95% CI: 67-74%) and hypercholesterolemia 66% (61-70%) followed by hypertriglyceridemia 26% (26-32%), hypertension 18% (15-21%) and diabetes 5% (4-7%). Metabolic syndrome showed 19% (95% CI: 16-23%) prevalence or, according to updated definitions (Clin Cornerstone 7 [2005] 36-45), 24% (95% CI: 20-28%). The rate of patients within the high-risk range of a 10-year fatal cardiovascular event was 6.5%. CVRFs under routine management were diabetes (60%), hypertension (28%) and, to a lesser extent, dyslipemia (14%). Treatment for CVRFs was associated to gender, men for hypertension OR = 25.34, p < 0.03 and women for diabetes OR = 0.02, p < 0.03. CONCLUSION: We found that CVRFs in schizophrenia were prevalent and under-diagnosed, and thus with insufficient therapeutic management.
No takes yet. Share an insight, caveat, or question.
Bernardo et al. (2009) conducted a cross-sectional in Schizophrenia (n=733). Schizophrenia treated with second generation antipsychotics was evaluated on Prevalence of cardiovascular risk factors. Among patients with schizophrenia, cardiovascular risk factors were highly prevalent, including smoking and hypercholesterolemia, but were under-diagnosed and insufficiently managed.
Synapse has enriched 10 related papers. Consider them for comparative context: